Cargando…
Global brain network dynamics predict therapeutic responsiveness to cannabidiol treatment for refractory epilepsy
Refractory epilepsy is a chronic brain network disorder characterized by unresponsiveness to multiple (>2) anti-epileptic drugs. Cannabidiol, a non-psychotropic neuroactive substance, is an emerging anti-epileptic treatment that was recently approved by the US Food and Drug Administration for the...
Autores principales: | Anderson, David E, Madhavan, Deepak, Swaminathan, Arun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751013/ https://www.ncbi.nlm.nih.gov/pubmed/33376981 http://dx.doi.org/10.1093/braincomms/fcaa140 |
Ejemplares similares
-
Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020) -
Cannabidiol for the treatment of refractory epilepsy in children: a critical review of the literature
por: Moreira, Gabriela Araujo, et al.
Publicado: (2022) -
Three Dimensional Brain Reconstruction Optimizes Surgical Approaches and Medical Education in Minimally Invasive Neurosurgery for Refractory Epilepsy
por: Swaminathan, Arun
Publicado: (2021) -
Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021) -
Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment
por: Gómez, Claudia Taborda, et al.
Publicado: (2021)